文献速递眼底病与葡萄膜炎

全美研究项目中通过稳态负荷测量的慢性压力与年龄相关性黄斑变性的关系

Relationship Between Chronic Stress Measured by Allostatic Load and Age-Related Macular Degeneration in the All of Us Research Program.
PubMed 文献 · Am J Ophthalmol · 2025-01-31

该回顾性病例对照研究纳入全美研究项目中1530名有完整稳态负荷生物标志物数据的参与者(221例年龄相关性黄斑变性患者,1309例对照),发现病例组诊断前中位9.0年的稳态负荷评分高于对照组,较高的基线稳态负荷评分与年龄相关性黄斑变性风险升高相关,慢性压力可能增加该病风险并可能贡献种族/民族患病率差异。

要点

  • 年龄相关性黄斑变性患者诊断前中位9.0年的稳态负荷评分高于对照(中位[IQR] 2[2-4] vs 2[1-3],P=0.02)。
  • 多变量分析中,较高的基线稳态负荷评分(OR=1.11)和更多的包年(每10包年OR=1.15)与年龄相关性黄斑变性风险升高相关(P≤0.02)。
  • 中介分析显示,其他特定种族/民族参与者相比非西班牙裔白人通过较高稳态负荷评分增加年龄相关性黄斑变性风险的间接效应显著(每单位OR=1.07[1.01-1.15])。

核心结论

  • 全美研究项目中诊断为年龄相关性黄斑变性的参与者在诊断前9.0年具有更高的稳态负荷评分。
  • 慢性压力似乎增加年龄相关性黄斑变性风险,并可能贡献疾病患病率的种族/民族差异。

研究设计与样本

  • 回顾性病例对照研究,纳入美国国立卫生研究院全美研究项目中1985年2月至2022年5月间有完整稳态负荷生物标志物数据且伴(病例)或不伴(对照)年龄相关性黄斑变性的参与者。
  • 稳态负荷评分采用改编的Seeman稳态负荷量表计算,包含10项系统性生物标志物:体重指数、收缩压、舒张压、总胆固醇、甘油三酯、肾小球滤过率、白蛋白、C反应蛋白和同型半胱氨酸;评分定义为处于最高风险四分位数的生物标志物测量数量。
  • 年龄计算为最早或最晚生物标志物测量时的中位年龄;主要结局为年龄相关性黄斑变性状态(年龄相关性黄斑变性或非年龄相关性黄斑变性)。
  • 采用逻辑回归模型在年龄和性别标准化并调整种族/民族和吸烟包年后评估稳态负荷评分与年龄相关性黄斑变性的关联;中介分析估计种族/民族与年龄相关性黄斑变性之间由稳态负荷评分中介的关系。

主要发现

  • 在1530名有完整生物标志物数据的参与者(221例病例,1309例对照)中,男性占44.6%,非西班牙裔白人占76.1%,其他特定种族/民族(亚洲人、黑人、西班牙裔)占18.6%,未指定种族/民族占5.3%。
  • 在诊断前中位9.0年(IQR=5.0-14.0)测量的稳态负荷评分,病例组高于对照组(中位[IQR]=2[2-4] vs 2[1-3];P=0.02)。
  • 多变量分析中,较高的基线稳态负荷评分(OR=1.11)和更多的包年(每10包年OR=1.15)与年龄相关性黄斑变性风险升高相关(P≤0.02)。
  • 中介分析显示,其他特定种族/民族参与者相比非西班牙裔白人参与者通过较高稳态负荷评分增加年龄相关性黄斑变性风险的间接效应显著(每单位OR=1.07[1.01-1.15])。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess the longitudinal relationship between age-related macular degeneration (AMD) and allostatic load (AL), an established framework for quantifying the physiologic effects of chronic stress through measurements of systemic biomarkers. DESIGN: Retrospective case-control study. METHODS: Participants of the National Institutes of Health All of Us (AoU) Research Program with complete AL biomarker data between February 1985 to May 2022 and with (cases) or without (controls) AMD were identified. AL scores were calculated using the adapted Seeman AL scale consisting of 10 systemic biomarkers: body mass index, systolic blood pressure, diastolic blood pressure, total cholesterol, triglycerides, glomerular filtration rate, albumin, C-reactive protein, and homocysteine. AL score was defined as the number of biomarkers with measurements in the highest risk quartiles. Age was calculated as the median age at time of earliest or latest biomarker measurements. The main outcome was AMD status (AMD or non-AMD). Logistic regression models assessed the association between AL score and AMD after standardization of age and sex and adjustment for race/ethnicity and pack-years of cigarette smoking. Mediation analysis estimated the relationship between race/ethnicity and AMD as mediated by AL score. RESULTS: Among 1530 participants (221 cases, 1309 controls) with complete biomarker data, there were 44.6% males, 76.1% non-Hispanic Whites (NHWs), 18.6% other specified race/ethnicity (Asian, Black, or Hispanic race/ethnicity), and 5.3% unspecified race/ethnicity. AL scores measured a median of 9.0 (IQR=5.0-14.0) years prior to diagnosis were higher among cases compared to controls (Median [IQR] = 2 [2-4] versus 2 [1-3]; P = .02). On multivariable analysis, higher baseline AL score (OR=1.11) and greater pack-years (OR=1.15 per 10 pack-years) conferred higher risk of AMD (P ≤ .02). Mediation analysis revealed a significant indirect effect that increased risk of AMD among other specified race/ethnicity participants compared to NHW participants through higher AL score (OR=1.07 per unit [1.01-1.15]). CONCLUSION: All of Us participants diagnosed with AMD had greater AL score 9.0 years prior to AMD diagnosis. Chronic stress appears to increase risk for AMD and may contribute to racial/ethnic differences in disease prevalence.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Yoo K, Wu L, Toy B, et al. Relationship Between Chronic Stress Measured by Allostatic Load and Age-Related Macular Degeneration in the All of Us Research Program. Am J Ophthalmol. 2025. PMID: 39894426. doi:10.1016/j.ajo.2025.01.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。